ARCHIVES

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

Tissue Bank Visibility Could Be Improved By Centralized Listing Of Resources: Panel

September 30, 1994

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

June 18, 1982

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997